Positron Emission Tomography Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Positron Emission Tomography stocks.

Positron Emission Tomography

Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body as an aid to the diagnosis of disease. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide, most commonly fluorine-18, which is introduced into the body on a biologically active molecule called a radioactive tracer. Three-dimensional images of tracer concentration within the body are then constructed by computer analysis. In modern PET-CT scanners, three-dimensional imaging is often accomplished with the aid of a CT X-ray scan performed on the patient during the same session, in the same machine.
If the biologically active tracer molecule chosen for PET is fludeoxyglucose (FDG), an analogue of glucose, the concentrations of tracer imaged will indicate tissue metabolic activity as it corresponds to the regional glucose uptake. Use of this tracer to explore the possibility of cancer metastasis (i.e., spreading to other sites) is the most common type of PET scan in standard medical care (representing 90% of current scans). Metabolic trapping of the radioactive glucose molecule allows the PET scan to be utilized. The same tracer may also be used for PET investigation and diagnosis of types of dementia. Less often, other radioactive tracers, usually but not always labeled with fluorine-18, are used to image the tissue concentration of other types of molecules of interest.
One of the disadvantages of PET scanners is their operating cost.

Browse All Tags